Joon Lee
Stock Analyst at Truist Securities
(4.74)
# 115
Out of 5,084 analysts
114
Total ratings
59.82%
Success rate
41.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $29.15 | +88.68% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $9.61 | +45.68% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $36.87 | +144.10% | 1 | Nov 5, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $90 → $80 | $53.34 | +49.98% | 3 | Oct 28, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $85 → $360 | $261.59 | +37.62% | 6 | Oct 17, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $29.54 | +48.95% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $905.62 | +1.37% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $458.53 | +6.86% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $77.30 | +11.25% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $38.83 | +93.15% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $12.75 | +64.71% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $83.94 | +78.70% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $150.92 | +32.52% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $58.63 | +104.67% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.73 | +382.57% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.97 | +168.01% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $7.58 | +374.93% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $23.15 | +55.54% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.44 | +227.87% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $10.77 | +57.85% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.20 | +853.52% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $169.71 | +17.85% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.19 | -3.66% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.32 | +316.67% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.73 | +16,113.09% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $44.36 | -23.35% | 1 | Mar 16, 2021 |
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $29.15
Upside: +88.68%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $9.61
Upside: +45.68%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $36.87
Upside: +144.10%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Buy
Price Target: $90 → $80
Current: $53.34
Upside: +49.98%
Praxis Precision Medicines
Oct 17, 2025
Reiterates: Buy
Price Target: $85 → $360
Current: $261.59
Upside: +37.62%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $29.54
Upside: +48.95%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $905.62
Upside: +1.37%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $458.53
Upside: +6.86%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $77.30
Upside: +11.25%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $38.83
Upside: +93.15%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $12.75
Upside: +64.71%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $83.94
Upside: +78.70%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $150.92
Upside: +32.52%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $58.63
Upside: +104.67%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.73
Upside: +382.57%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.97
Upside: +168.01%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $7.58
Upside: +374.93%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.15
Upside: +55.54%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.44
Upside: +227.87%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.77
Upside: +57.85%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.20
Upside: +853.52%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $169.71
Upside: +17.85%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.19
Upside: -3.66%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.32
Upside: +316.67%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.73
Upside: +16,113.09%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $44.36
Upside: -23.35%